AngioDynamics to Hold Fiscal Second Quarter Financial Results Conference Call on Monday, December 20, 2004

December 14, 2004 at 12:00 AM EST
AngioDynamics to Hold Fiscal Second Quarter Financial Results Conference Call on Monday, December 20, 2004QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 14, 2004--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that the company will release its fiscal second quarter results on Monday, December 20, 2004 after market close.

Eamonn P. Hobbs, president and chief executive officer, and Joseph G. Gerardi, chief financial officer, will host an investment community conference call beginning at 4:30 p.m. Eastern Time on December 20th to discuss these results and to answer questions.

To participate in the live call by telephone, please dial (888) 804-7108 from the U.S., or for international callers, please dial (706) 634-1250.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics' web site at http://investor.angiodynamics.com/. To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download, and install the necessary audio software.

A replay will be available on the Web site for 14 days. A telephone replay will be available from 7:30 p.m. Eastern Time December 20, 2004 through 11:59 p.m. Eastern Time on December 22, 2005 by dialing (888) 642-1687 (domestic) or (706) 645-9291 (international) and entering conference ID number 2682091.

About AngioDynamics



AngioDynamics, Inc. (www.angiodynamics.com) designs, develops, manufactures and markets innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease. It offers a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. AngioDynamics' diversified product line includes angiographic catheters, hemodialysis catheters, PTA dilation catheters, thrombolytic products, image-guided vascular access products, endovascular laser venous system products, as well as drainage products.

    CONTACT: AngioDynamics, Inc.
             Joe Gerardi, 800-772-6446 x115
             www.AngioDynamics.com
             or
             Investor Relations Contacts:
             Lippert/Heilshorn & Associates, Inc.
             Kim Sutton Golodetz, 212-838-3777
             kgolodetz@lhai.com
             Bruce Voss, 310-691-7100
             bvoss@lhai.com

    SOURCE: AngioDynamics, Inc.